UK's Oxford Nanopore gains on FY revenue forecast
** Shares of British biotech firm Oxford Nanopore
Technologies ONT.L surge 21.6% to 158.75p
** Co expects to report FY revenue of about 183 mln pounds
($222.27 million) vs 169.7 mln pounds in FY23
** Says increase in revenue is due to expansion into new
sectors outside of research, including applied industrial,
biopharma and clinical
** Co reaffirms medium-term guidance
** Stock fell ~36% in 2024
($1 = 0.8233 pounds)
(Reporting by Ankita Bora in Bengaluru)
((Ankita.Bora@thomsonreuters.com))
Recent news on Oxford Nanopore Technologies
See all newsBrief: Oxford Nanopore Technologies Says Nick Keher, CFO, To Assume Additional Responsibilities From July 1, 2026
Oxford Nanopore Tech - Changes to Director Roles and Responsibilities
UK's IP Group rebuffs top investor Railpen's $810 million takeover proposal
Brief: Railways Pension Trustee Company Limited Announces Possible Offer For All IP Group Shares
Oxford Nanopore Tech - Share Incentive Plan - Director/PDMR Shareholding